Taken together, these results suggest that Ca2+ and ROS dysregulation may be associated with the pathogenesis of developmental delay, RCM, and spasticity characterized in patients with the identified DCBLD2 variant. This evidence concerns the gene DCBLD2 and Global developmental delay.